EP3426294
LYFJABLANDA SEM INNIHELDUR MÓTEFNI, SÝKLÓDEXTRÍN OG METÓNÍN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.3.2017EP published:
17.5.2023EP application number:
17710208.4
EP translation filed:
13.6.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
8.3.2037Expiry date:
8.3.2027Next due date:
31.3.2027
Title in English:
PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY, CYCLODEXTRIN AND METHIONINELanguage of the patent:
English
Timeline
Today
9.3.2017EP application
17.5.2023EP Publication
13.6.2023Translation submitted
15.8.2023Registration published
8.3.2027Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allée de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
YATES, Andrew JeffreyAddress:
Victoria 3144, AU
Name:
CLIPSTONE, James GregoryAddress:
Slough Berkshire SL1 3WE, GB
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201604124Date:
10.3.2016Country:
GB
Classification
Categories:
A61K 9/00, A61P 19/08, A61K 47/20, A61K 39/395, A61P 19/10, A61P 29/00, C07K 16/22, A61K 47/18, A61K 9/08, A61K 47/40
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 12.2.2024
Expires: 8.3.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.2.2025
Expires: 8.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.3.2026
Expires: 8.3.2027
Payer: Árnason Faktor ehf.